CommercialCoverageMedium impact
23-1178sum Summary Update: Medication Trend Updates and Formulary - 4th Quarter 2023
Health Net·CA·Pharmacy
We identified it
Jun 20, 2026
Summary
Health Net updated their formularies for Q4 2023, including approval of RiVive as a second OTC naloxone nasal spray and changes to preferred biosimilar medications across Commercial, Medi-Cal, and Medicare Part D formularies.
Action Required
Review the complete update 23-1178 (PDF) on Health Net provider portal under Provider Library > Updates and Letters > Updates and Letters for 2023 and Beyond to identify specific formulary changes affecting your specialty. Contact appropriate pharmacy help lines for questions: Commercial 800-548-5524 option 3, Medi-Cal Rx 800-977-2273, Medicare 800-867-6564.